I did some solid research today and in my opinion we're better off with IMU. Solid Management, Excellent Results, and most importantly genuine integrity is what I'm seeing. Biotech in general is a risky and volatile investment so ofcourse everybody should do their own research. I was looking at IVX, PTX, and BNO. I'm going all in on IMU gentlemen. I have a strong gut feeling the investments and genuine research will pay-off in the long term. IMU is extremely undervalued still IMHO. Just do a research on Paul Hopper, he's been associated with crucial Biotech firms and did wonders for Viralytics. I have no doubt in his abilities to help IMU get its fair valuation in a future partnership. Again, DYOR.
Add to My Watchlist
What is My Watchlist?
